For details, see: Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
This evidence gap shapes everything we can say about BPC-157 and cardiovascular health
14,15 Extreme stress and eating disorders can disrupt hypothalamic signaling, leading to ovarian dysfunction and anovulation
McGavock Chair, the Immunotherapy Program in the Department of Medicine, the U.S
Conversion charts are a starting point for conversation, not a prescription
Lixisenatide is structurally related to exendin-4 (six lysine residues have been added to the C terminus, and one proline in the C-terminal region has been deleted) but can be administered once daily (QD)